David Marín
- Hematology top 0.1%
- Genetics top 0.1%
- Rheumatology top 0.5%
- Public Health, Environmental and Occupational Health top 5%
- Oncology top 5%
- Co-authors
- Jane F. ApperleyJohn M. GoldmanDragana MilojkovićMarco BuaRichard SzydloAlistair ReidJamshid S. KhorashadLetizia Foroni
- Topics
- Chronic Myeloid Leukemia Treatments (74 papers)Chronic Lymphocytic Leukemia Research (66 papers)Eosinophilic Disorders and Syndromes (46 papers)
- Cited by
- HematologyGeneticsFamily Practice
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
David Marín
111 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Hematology 3.3k
- Genetics 2.7k
- Rheumatology 1.6k
- Public Health, Environmental and Occupational Health 509
- Oncology 473
Countries citing papers authored by David Marín
This map shows the geographic impact of David Marín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Marín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Marín more than expected).
Fields of papers citing papers by David Marín
This network shows the impact of papers produced by David Marín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Marín. The network helps show where David Marín may publish in the future.
Co-authorship network of co-authors of David Marín
This figure shows the co-authorship network connecting the top 25 collaborators of David Marín. A scholar is included among the top collaborators of David Marín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Marín. David Marín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 3 | |
| 3 | 14 | |
| 4 | 3 | |
| 5 | 11 | |
| 6 | 3 | |
| 7 | 14 | |
| 8 | 52 | |
| 9 | 23 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 32 | |
| 13 | 61 | |
| 14 | Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinibbreakdown → | 674 |
| 15 | 15 | |
| 16 | 416 | |
| 17 | 144 | |
| 18 | 8 | |
| 19 | 14 | |
| 20 | 27 |
About David Marín
David Marín is a scholar working on Hematology, Genetics and Rheumatology, having authored 114 papers that have together received 4.0k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (74 papers), Chronic Lymphocytic Leukemia Research (66 papers) and Eosinophilic Disorders and Syndromes (46 papers). The work is most often cited by research in Hematology (3.3k citations), Genetics (2.7k citations) and Family Practice (248 citations). David Marín has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Jane F. Apperley, John M. Goldman, Dragana Milojković, Marco Bua, Richard Szydlo, Alistair Reid, Jamshid S. Khorashad, Letizia Foroni, Hugues de Lavallade and Eduardo Olavarría. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.